Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120472528 | 12047252 | 8 | F | 20160228 | 20160719 | 20160209 | 20160727 | EXP | US-ASTRAZENECA-2015SE78238 | ASTRAZENECA | 26660.00 | DY | F | Y | 55.20000 | KG | 20160727 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120472528 | 12047252 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | Y | U | 206995 | TABLET | ||||||||
| 120472528 | 12047252 | 2 | SS | TAGRISSO | OSIMERTINIB | 1 | Oral | U | U | FN0072 | 0 | 80 | MG | TABLET | QD | ||||
| 120472528 | 12047252 | 3 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 120472528 | 12047252 | 4 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120472528 | 12047252 | 1 | Metastases to lung |
| 120472528 | 12047252 | 2 | Lung carcinoma cell type unspecified stage 0 |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120472528 | 12047252 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120472528 | 12047252 | Decreased appetite | |
| 120472528 | 12047252 | Diarrhoea | |
| 120472528 | 12047252 | Disease progression | |
| 120472528 | 12047252 | Drug dose omission | |
| 120472528 | 12047252 | Dyspnoea | |
| 120472528 | 12047252 | Fatigue | |
| 120472528 | 12047252 | Muscle spasms | |
| 120472528 | 12047252 | Nasopharyngitis | |
| 120472528 | 12047252 | Nausea | |
| 120472528 | 12047252 | Pruritus | |
| 120472528 | 12047252 | Skin burning sensation | |
| 120472528 | 12047252 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120472528 | 12047252 | 2 | 20160205 | 0 |